Internship
Spring 2025 Co-op: Guide RNA Chemistry
Confirmed live in the last 24 hours
Gene editing technology for genetic diseases
Belmont, MA, USA
Candidates must be from the local Boston/Cambridge area.
Prime Medicine focuses on gene editing, specifically using a technology called Prime Editing to make precise changes to DNA. This technology can identify and fix faulty DNA segments, which helps restore normal genetic function. The company aims to cure, halt, or prevent genetic diseases, providing long-term benefits to patients. Prime Medicine targets individuals with genetic disorders, a significant market globally. Unlike many competitors, Prime Medicine collaborates with research institutions and pharmaceutical companies to advance its technology and generate revenue through licensing and partnerships. The leadership team, including experienced professionals like Chief Technical Officer Ann L. Lee, is dedicated to enhancing the company's technological capabilities and expanding operations.
Company Stage
N/A
Total Funding
$596M
Headquarters
Cambridge, Massachusetts
Founded
2019